4D Medicine Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Series E2

  • Latest Deal Amount
  • $9.7M

  • Investors
  • 12

4D Medicine General Information

Description

Manufacturer of degradable, implantable medical devices made from novel photopolymer materials. The company is taking a range of devices through regulatory clearance with the FDA(Food and Drug Administration)) before commercial launch, helping medical device suppliers provide patients with resorbable medical devices that help optimize outcomes in applications such as musculoskeletal surgery, soft tissue repair, and drug delivery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • D6 West Building, Medicity
  • 1 Thane Road
  • Nottingham NG90 6BH
  • England, United Kingdom
Primary Industry
Other Devices and Supplies
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • D6 West Building, Medicity
  • 1 Thane Road
  • Nottingham NG90 6BH
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

4D Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series E2) 05-Dec-2025 $9.7M Completed Generating Revenue
6. Later Stage VC (Series A2) 10-Dec-2024 Cancelled Generating Revenue
5. Seed Round 20-Jul-2021 Completed Generating Revenue
4. Grant 01-Jan-2021 Completed Startup
3. Grant 01-Jun-2020 Completed Startup
2. Seed Round 27-May-2020 $346K $346K Completed Startup
1. University Spin-Out 01-Oct-2018 Completed Startup
To view 4D Medicine’s complete valuation and funding history, request access »

4D Medicine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C3 Ordinary
C2 Ordinary
C1 Ordinary
B Ordinary
A Ordinary 9,349 $0.000138 $59.75 $59.75 1x $59.75 9.98%
A Ordinary 15,065 $0.000138 $25.82 $25.82 1x $25.82 16.09%
To view 4D Medicine’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

4D Medicine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of degradable, implantable medical devices made from novel photopolymer materials. The company is taking a
Other Devices and Supplies
Nottingham, United Kingdom
11 As of 2025

Ithaca, NY
 

United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

4D Medicine Competitors (7)

One of 4D Medicine’s 7 competitors is Transonic, a Private Debt Financed company based in Ithaca, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Transonic Private Debt Financed Ithaca, NY
Invibio Corporation United Kingdom
Healionics Venture Capital-Backed Seattle, WA
Angiodynamics Corporation Latham, NY
Cordis Private Equity-Backed Miami Lakes, FL
You’re viewing 5 of 7 competitors. Get the full list »

4D Medicine Patents

4D Medicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202107999-D0 Biodegradable polymers Inactive 04-Jun-2021
GB-2607588-A Biodegradable polymers Inactive 04-Jun-2021
EP-4348351-A1 Biodegradable polymers that elute an active substance Pending 04-Jun-2021
US-20240279374-A1 Biodegradable polymers that elute an active substance Pending 04-Jun-2021
WO-2022254173-A1 Biodegradable polymers that elute an active substance Inactive 04-Jun-2021 C08F2/48
To view 4D Medicine’s complete patent history, request access »

4D Medicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

4D Medicine Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boundary Capital Partners Venture Capital Minority
British Business Bank Lender/Debt Provider Minority
Norcliffe Capital Venture Capital Minority
Oshen Holdings Family Office Minority
Wealth Club Corporation Minority
You’re viewing 5 of 12 investors. Get the full list »

4D Medicine FAQs

  • When was 4D Medicine founded?

    4D Medicine was founded in 2018.

  • Where is 4D Medicine headquartered?

    4D Medicine is headquartered in Nottingham, United Kingdom.

  • What is the size of 4D Medicine?

    4D Medicine has 11 total employees.

  • What industry is 4D Medicine in?

    4D Medicine’s primary industry is Other Devices and Supplies.

  • Is 4D Medicine a private or public company?

    4D Medicine is a Private company.

  • What is 4D Medicine’s current revenue?

    The current revenue for 4D Medicine is .

  • How much funding has 4D Medicine raised over time?

    4D Medicine has raised $12.3M.

  • Who are 4D Medicine’s investors?

    Boundary Capital Partners, British Business Bank, Norcliffe Capital, Oshen Holdings, and Wealth Club are 5 of 12 investors who have invested in 4D Medicine.

  • Who are 4D Medicine’s competitors?

    Transonic, Invibio, Healionics, Angiodynamics, and Cordis are some of the 7 competitors of 4D Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process